Nichols & Pratt Advisers’s Biogen BIIB Stock Holding History

Nichols & Pratt Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-702	Closed	-$211K	–	107
2018 Q4	$211K	Hold	702	–	–	0.02%	98
2018 Q3	$248K	Hold	702	–	–	0.02%	103
2018 Q2	$204K	Buy	+702	New	+$197K	0.02%	108
2018 Q1	–	Sell	-702	Closed	-$224K	–	112
2017 Q4	$224K	Hold	702	–	–	0.02%	108
2017 Q3	$220K	Buy	+702	New	+$208K	0.02%	106
2016 Q4	–	Sell	-800	Closed	-$251K	–	105
2016 Q3	$251K	Buy	+800	New	+$237K	0.02%	101
2016 Q2	–	Sell	-800	Closed	-$208K	–	120
2016 Q1	$208K	Hold	800	–	–	0.02%	118
2015 Q4	$245K	Hold	800	–	–	0.02%	111
2015 Q3	$234K	Hold	800	–	–	0.02%	108
2015 Q2	$323K	Sell	800 -100	-11%	-$40.1K	0.03%	98
2015 Q1	$380K	Hold	900	–	–	0.03%	95
2014 Q4	$306K	Hold	900	–	–	0.03%	106
2014 Q3	$298K	Hold	900	–	–	0.03%	105
2014 Q2	$284K	Hold	900	–	–	0.02%	109
2014 Q1	$275K	Hold	900	–	–	0.02%	99
2013 Q4	$252K	Hold	900	–	–	0.02%	86
2013 Q3	$217K	Sell	900 -100	-10%	-$22.4K	0.02%	86
2013 Q2	$215K	Buy	+1,000	New	+$214K	0.02%	88

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nichols & Pratt Advisers's BIIB Position: Q1 2019 in Review

Nichols & Pratt Advisers sold out of Biogen (BIIB) in Q1 2019, closing a stake of 702 shares — an estimated $211K sold.

Nichols & Pratt Advisers first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $380K in Q1 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Nichols & Pratt Advisers reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Nichols & Pratt Advisers sold 702 Biogen shares in Q1 2019, an estimated $211K.
Nichols & Pratt Advisers first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
Nichols & Pratt Advisers's Biogen position peaked at $380K in Q1 2015.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2019, filed 30 Apr 2019.